U.S. In Vitro Diagnostics Market worth 25.99 Billion USD by 2020 U.S. In Vitro Diagnostics Market worth 25.99 Billi | Page 20

LIST OF FIGURES • FIGURE 1 U.S. IN VITRO DIAGNOSTICS MARKET.............................................................................................................15 • FIGURE 2 RESEARCH DESIGN.................................................................. .........................................................................17 • FIGURE 3 BOTTOM-UP APPROACH..................................................................................................................................21 • FIGURE 4 TOP-DOWN APPROACH....................................................................................................................................21 • FIGURE 5 DATA TRIANGULATION METHODOLOGY...........................................................................................................22 • FIGURE 6 U.S. IVD MARKET SIZE, BY PRODUCTS & SERVICES, 2015 VS. 2020 (USD MILLION)...................................24 • FIGURE 7 U.S. IVD INSTRUMENTS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION).........................................25 • FIGURE 8 U.S. IVD MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 (USD MILLION)....................................................26 • FIGURE 9 U.S. IVD MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION).....................................................27 • FIGURE 10 U.S. IVD MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)..........................................................27 • FIGURE 11 U.S. IVD MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)..............................................................28 • FIGURE 12 GROWING PREVALENCE OF CHRONIC DISEASES AND INCREASING DEMAND FOR AUTOMATED INSTRUMENTS TO DRIVE MARKET GROWTH...................................................................................................29 • FIGURE 13 HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE U.S. IVD END-USERS MARKET IN 2014.....................................................................................................30 • FIGURE 14 SOUTH REGION TO DOMINATE THE U.S. IVD MARKET DURING 2015 TO 2020..............................................31 • FIGURE 15 U.S. IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY PRODUCT..........................................................34 • FIGURE 16 U.S. IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY...................................................34 • FIGURE 17 U.S. IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY APPLICATION....................................................35 • FIGURE 18 U.S. IN VITRO DIAGNOSTICS MARKET SEGMENTATION, BY END USER..........................................................35 • FIGURE 19 U.S. IVD MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES..............................................36 • FIGURE 20 NUMBER OF PATIENTS WITH CHRONIC CONDITION IN THE U.S. (IN MILLION).............................................37 • FIGURE 21 REAGENTS, THE FASTEST GROWING SEGMENT OF THE U.S. IVD MARKET DURING 2015-2020...................44 • FIGURE 22 THE MOLECULAR DIAGNOSTICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD....................................................................................................................................53 • FIGURE 23 ONCOLOGY SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD..................62 • FIGURE 24 PREVALENCE OF CARDIOVASCULAR DISEASES IN ADULTS AGED ≥20 YEARS..............................................67 • FIGURE 25 U.S. IVD MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)..........................................................75 • FIGURE 26 U.S. CLINICAL LABORATORIES MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)..............................78 [email protected] www.marketsandmarkets.com 20